Marker Therapeutics, Inc.
NASDAQMarker Therapeutics arrives at its May 21 Q1 earnings call in a markedly different position than it held six weeks ago — short sellers have been cutting exposure sharply, the stock slipped another 11% over the past month, and a beat on last night's preliminary numbers has done little to arrest the drift. The most striking development in the positioning data is just how aggressively…
Snapshot as of 16 May 2026
Marker Therapeutics arrives at its May 21 Q1 earnings call in a markedly different position than it held six weeks ago — short sellers have been cutting exposure sharply, the stock slipped another 11% over the past…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MRKR — free to start on ORTEX.
Sign up for free →Open MRKR on ORTEX